EUROPHARMA.DK ApS: Financial statements 2012
CVR: 34601933
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
EUROPHARMA.DK ApS (CVR 34601933) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 14,611,263 and a net result of DKK -48,658. Equity in the 2012 report amounted to DKK 951,342. The solvency ratio was 0.9%. The company had 29 employees in the financial year.
- Gross Profit
- DKK 14,611,263
- Profit/Loss
- DKK -48,658
- Equity
- DKK 951,342
- Total Assets
- DKK 105,621,510
- Employees
- 29
Official annual report
Keep an eye on EUROPHARMA.DK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
On October 30, 2012, the company changed its name from EUROPHARMA.DK 2012 ApS to EUROPHARMA.DK ApS.
On October 9, 2012, the company changed its name from EUROPHARMA.DK 2012 ApS UNDER STIFTELSE to EUROPHARMA.DK 2012 ApS.
As of June 22, 2012, Partner Revision statsautoriseret revisionsaktieselskab has been appointed auditor of EUROPHARMA.DK ApS.
As of June 22, 2012, Torben Hvingelby Pedersen is registered as director of EUROPHARMA.DK ApS.
EUROPHARMA.DK ApS was founded on June 22, 2012.
About EUROPHARMA.DK ApS
EUROPHARMA.DK ApS was a Danish company of the type Anpartsselskab based in Esbjerg N, founded in 2012. The company has been dissolved. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named EUROPHARMA.DK 2012 ApS and EUROPHARMA.DK 2012 ApS UNDER STIFTELSE. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK 29,260,677 and a net result of DKK 6,540,655 compared with DKK 311,702 the year before. Equity in the 2016 report amounted to DKK 80,610,926.